Site-specific mRNA cleavage for selective and quantitative profiling of alternative splicing with label-free optical biosensors.

Alternative Splicing of messenger RNA precursors is a key process in gene regulation, contributing to the diversity of proteomes by the alternative selection of exonic sequences. Most cancers are associated with alterations in this mechanism, enhancing their proliferation and survival, and can be employed as cancer biomarkers. Label-free optical biosensors are ideal tools for the highly sensitive and label-free analysis of nucleic acids. However, their application for alternative splicing analysis has been hampered due to the formation of complex and intricate long-range base-pairing interactions which make the direct detection in mRNA isoforms difficult. To solve this bottleneck, we introduce a methodology for the generation of length-controlled RNA fragments from purified total RNA, which can be easily detected by the biosensor. The methodology seizes RNase H enzyme activity to degrade the upstream and downstream RNA segments flanking the target sequence upon hybridization to specific DNA-oligos. It allows the fast and direct monitoring of Fas gene alternative splicing in real-time employing a Surface Plasmon Resonance (SPR) biosensor. We demonstrate the selective and specific detection of mRNA fragments in the pM-nM concentration range, reducing quantification errors and showing 81% accuracy when compared to RT-qPCR. The site-specific cleavage outperformed a random RNA hydrolysis by increasing the detection accuracy in 20%, making this methodology particularly appropriate for label-free quantification of alternative splicing events in complex samples.

[1]  L. Lechuga,et al.  Advanced Evanescent-Wave Optical Biosensors for the Detection of Nucleic Acids: An Analytic Perspective , 2019, Front. Chem..

[2]  Shanrong Zhao Alternative splicing, RNA-seq and drug discovery. , 2019, Drug discovery today.

[3]  Laura M Lechuga,et al.  Label-free plasmonic biosensors for point-of-care diagnostics: a review , 2018, Expert review of molecular diagnostics.

[4]  L. Lechuga,et al.  Label-free DNA-methylation detection by direct ds-DNA fragment screening using poly-purine hairpins. , 2018, Biosensors & bioelectronics.

[5]  R. May,et al.  Alternative splice variants of DCLK1 mark cancer stem cells, promote self‐renewal and drug‐resistance, and can be targeted to inhibit tumorigenesis in kidney cancer , 2018, International journal of cancer.

[6]  Petr Smirnov,et al.  Gene isoforms as expression-based biomarkers predictive of drug response in vitro , 2017, Nature Communications.

[7]  S. Knapp,et al.  Alternative splicing promotes tumour aggressiveness and drug resistance in African American prostate cancer , 2017, Nature Communications.

[8]  J. M. Suñé-Negre,et al.  Targeting Splicing in the Treatment of Human Disease , 2017, Genes.

[9]  L. Lechuga,et al.  Analysis of alternative splicing events for cancer diagnosis using a multiplexing nanophotonic biosensor , 2017, Scientific Reports.

[10]  J. Valcárcel,et al.  Quantitative evaluation of alternatively spliced mRNA isoforms by label-free real-time plasmonic sensing. , 2016, Biosensors & bioelectronics.

[11]  M. Swanson,et al.  RNA mis-splicing in disease , 2015, Nature Reviews Genetics.

[12]  D. Bates,et al.  Hallmarks of alternative splicing in cancer , 2014, Oncogene.

[13]  J. Homola,et al.  Surface plasmon resonance sensing of nucleic acids: a review. , 2013, Analytica chimica acta.

[14]  Emily M. LeProust,et al.  Synthesis of high-quality libraries of long (150mer) oligonucleotides by a novel depurination controlled process , 2010, Nucleic acids research.

[15]  R. Crouch,et al.  Ribonuclease H: the enzymes in eukaryotes , 2009, The FEBS journal.

[16]  L M Lechuga,et al.  Label-free detection of DNA mutations by SPR: application to the early detection of inherited breast cancer , 2009, Analytical and bioanalytical chemistry.

[17]  Jyoti K. Shah,et al.  Differential expression of 24 , 426 human alternative splicing events and predicted cis-regulation in 48 tissues and cell lines , 2011 .

[18]  Robert Castelo,et al.  Regulation of Fas alternative splicing by antagonistic effects of TIA-1 and PTB on exon definition. , 2005, Molecular cell.

[19]  L. Owen-Schaub,et al.  Fas and Fas ligand interactions in malignant disease. , 2000, International journal of oncology.

[20]  S. E. Harvey,et al.  Methods for Characterization of Alternative RNA Splicing. , 2016, Methods in molecular biology.